Crossmark

Intracoronary administration of tenecteplase to prevent PCI-related myocardial infarction in patients with echo-attenuated coronary plaques: study protocol for a multicenter, prospective, randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-024-08605-9

Published Online: 2024-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hong, Xu-Lin

Loh, Yi-Hao

Li, Duan-Bin

Luan, Yi

Zhang, Wen-Bin
License Information

Text and Data Mining valid from 2024-11-25

Version of Record valid from 2024-11-25
More Information

Article History

Received: 18 June 2024

Accepted: 1 November 2024

First Online: 25 November 2024

Declarations

:

: This trial protocol has been conducted in agreement with the ethics guidelines of the 1975 Declaration of Helsinki, and the Medical Ethics Committee of the Sir Run Run Shaw Hospital of Zhejiang University has approved the study design, protocols, information letters, and informed consent form.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below